Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06823947

Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension

Conditions: Healthy Volunteers Essential Hypertension

Sex: All

Ages: 18 Years – 80 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 160

Sponsor: Kyowa Kirin Co., Ltd.

Location: SOUSEIKAI PS Clinic Hakata Fukuoka

Summary

Part 1 : To evaluate the safety of single-dose KK3910 in healthy volunteers. Part 2 : To evaluate the safety of multiple-dose KK3910 in patients with essential hypertension. Part 3 : To assess the safety profile of repeated dosing of KK3910 in an additional hypertension cohort.

Eligibility Criteria

Inclusion Criteria: Part 1 * Voluntary consent to participate in this study must be given (in writing) * Japanese healthy adults or non-Asian healthy men 18 to \< 55 years at the time of informed consent ( Japanese healthy adults 65 to \< 80 years for the elderly cohort) * BMI is within the specified range at screening Inclusion Criteria: Part 2 * Voluntary consent to participate in this study must be given (in writing) * Japanese patients with essential hypertension, aged 18 to \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06823947). StuddyBuddy aggregates publicly available trial information.